These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 23969177

  • 1. Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis.
    Tumati S, Martens S, Aleman A.
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2571-86. PubMed ID: 23969177
    [Abstract] [Full Text] [Related]

  • 2. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
    Wang H, Tan L, Wang HF, Liu Y, Yin RH, Wang WY, Chang XL, Jiang T, Yu JT.
    J Alzheimers Dis; 2015 Dec; 46(4):1049-70. PubMed ID: 26402632
    [Abstract] [Full Text] [Related]

  • 3. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T, Xiao S, Li X, Ding B, Ling H, Chen K, Fang Y.
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [Abstract] [Full Text] [Related]

  • 4. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z, Zhao C, Yu L, Zhou W, Li K.
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [Abstract] [Full Text] [Related]

  • 5. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM, Daly EM, Glover A, O'Gorman R, Simmons A, Murphy DG, Lovestone S.
    Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
    [Abstract] [Full Text] [Related]

  • 6. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP.
    Neurosci Lett; 2011 Oct; 384(1-2):23-8. PubMed ID: 15905028
    [Abstract] [Full Text] [Related]

  • 7. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Targosz-Gajniak MG, Siuda JS, Wicher MM, Banasik TJ, Bujak MA, Augusciak-Duma AM, Opala G.
    J Neurol Sci; 2013 Dec 15; 335(1-2):58-63. PubMed ID: 24035276
    [Abstract] [Full Text] [Related]

  • 8. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M, Melzer TR, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Wood KL, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.
    Parkinsonism Relat Disord; 2016 Jan 15; 22():54-61. PubMed ID: 26627939
    [Abstract] [Full Text] [Related]

  • 9. Proxies of cognitive reserve and their effects on neuropsychological performance in patients with mild cognitive impairment.
    Liu Y, Cai ZL, Xue S, Zhou X, Wu F.
    J Clin Neurosci; 2013 Apr 15; 20(4):548-53. PubMed ID: 23406880
    [Abstract] [Full Text] [Related]

  • 10. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.
    Dement Geriatr Cogn Disord; 2008 Apr 15; 26(1):15-25. PubMed ID: 18566544
    [Abstract] [Full Text] [Related]

  • 11. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
    Guo Z, Liu X, Hou H, Wei F, Chen X, Shen Y, Chen W.
    Compr Psychiatry; 2016 Aug 15; 69():179-85. PubMed ID: 27423359
    [Abstract] [Full Text] [Related]

  • 12. Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.
    Yang ZX, Huo SS, Cheng XF, Xu ZF, Cao Z, Zeng JX, Xiao YY, You KZ, Chen W, Liu YY, Wu RH.
    Neuroradiology; 2012 May 15; 54(5):451-8. PubMed ID: 21739221
    [Abstract] [Full Text] [Related]

  • 13. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
    Suriyajakryuththana W, Tuntiyatorn L, Teepprasarn N, Sukying C.
    J Med Assoc Thai; 2014 Apr 15; 97(4):407-14. PubMed ID: 24964683
    [Abstract] [Full Text] [Related]

  • 14. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M, Moriya M, Nojo T.
    J Alzheimers Dis; 2017 Apr 15; 60(4):1411-1427. PubMed ID: 28968236
    [Abstract] [Full Text] [Related]

  • 15. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
    Metastasio A, Rinaldi P, Tarducci R, Mariani E, Feliziani FT, Cherubini A, Pelliccioli GP, Gobbi G, Senin U, Mecocci P.
    Neurobiol Aging; 2006 Jul 15; 27(7):926-32. PubMed ID: 15936850
    [Abstract] [Full Text] [Related]

  • 16. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD, Rai GS.
    Neuroradiology; 2003 Aug 15; 45(8):507-12. PubMed ID: 12879326
    [Abstract] [Full Text] [Related]

  • 17. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 15; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 18. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Su L, Blamire AM, Watson R, He J, Hayes L, O'Brien JT.
    Transl Psychiatry; 2016 Aug 30; 6(8):e877. PubMed ID: 27576166
    [Abstract] [Full Text] [Related]

  • 19. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM, Heinze HJ, Kaufmann J.
    J Alzheimers Dis; 2013 Aug 30; 36(1):155-63. PubMed ID: 23579327
    [Abstract] [Full Text] [Related]

  • 20. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment.
    Nie K, Zhang Y, Huang B, Wang L, Zhao J, Huang Z, Gan R, Wang L.
    Parkinsonism Relat Disord; 2013 Mar 30; 19(3):329-34. PubMed ID: 23238068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.